Walmart and Amazon Are Competitors, Not Monopolies

In a recent column published in RealClearMarkets, Market Institute President Charles Sauer explains how Walmart’s rise to a trillion-dollar company illustrates the power of free markets—and why policymakers should rethink modern antitrust enforcement. Walmart recently became only the second non-technology company to surpass a $1 trillion market capitalization, joining Warren Read more…

TrumpRx Is a Prescription for Failure

In a recent article for RealClearHealth, Market Institute President Charles Sauer warns that the Trump administration’s new TrumpRx initiative may deliver lower drug prices in the short run—but at the cost of future medical innovation. Sauer explains that while the goal of lowering pharmaceutical prices is laudable, the method matters. Read more…